New Trial Shows Deferring Coronary Stenting Before Heart Valve Replacement Safe for Elderly Patients

New PRO-TAVI study finds deferring coronary intervention before heart valve replacement is safe for elderly patients and reduces major bleeding risks.

By: AXL Media

Published: Mar 30, 2026, 3:54 AM EDT

Source: Information for this report was sourced from American College of Cardiology

A Shift in Procedural Priority for High Risk Cardiac Patients

The traditional clinical approach of clearing coronary blockages before replacing a failing heart valve is being challenged by new data from the Netherlands. According to Michiel Voskuil, an interventional cardiologist at University Medical Center Utrecht, elderly patients with both coronary artery disease and aortic stenosis can safely prioritize the valve replacement. The PRO-TAVI study indicates that performing transcatheter aortic valve replacement, or TAVR, without prior percutaneous coronary intervention, known as PCI, results in clinical outcomes that are non-inferior to the conventional dual-procedure strategy. This shift suggests that for the most vulnerable populations, a less is more approach may provide the necessary relief without the added burden of preparatory surgeries.

Challenging the Standards of Transatlantic Clinical Practice

Current medical standards for treating combined valve and artery disease vary significantly between the United States and Europe, creating a divide in surgical philosophy. In the American healthcare landscape, clinicians typically favor performing PCI to stabilize blood flow before addressing the valve, particularly in younger, lower-risk demographics. Conversely, European practitioners, who often treat a much older and higher-risk patient base, have historically leaned toward deferring artery work. The PRO-TAVI findings validate the European model, suggesting that the urgency of the valve malfunction often outweighs the immediate need for stenting in patients who are frequently over the age of 80.

Quantifying Survival and Safety Metrics in the PRO-TAVI Trial

The rigorous study, which tracked 466 patients across a three-year period, focused on a composite endpoint of death, heart attack, and stroke. The data showed that approximately 24.1% of patients who deferred artery treatment experienced these major events, compared to 25.8% of those who received the intervention first. These figures met the trial's specific threshold for non-inferiority, effectively proving that there is no statistical advantage to the more invasive pre-emptive stenting. By focusing on these high-risk individuals, the trial demonstrated that the added complexity of multiple catheter-based procedures does not necessarily translate to a longer or healthier life for the patient.